On September 25th, Simcere Pharma (stock code 02096) spent 13.2814 million Hong Kong dollars to repurchase 2.135 million shares.
Sinopharm Group Co., Ltd. (02096) announced that it will spend 1328.14 million Hong Kong dollars to repurchase...
SIMCERE PHARMA (02096) announced that it repurchased 213.5 million shares for a total of HK$1328.14 million on September 25, 2024.
Related Articles
Hunan Silver (002716.SZ) director Rongqi resigns
Jiangsu Linyang Energy (601222.SH) holding shareholder Huahong Electronics plans to increase its holdings by 50-100 million yuan.
China National Nuclear Power (601985.SH): Jiangsu Lianyungang Port plans to sell 4% equity stake in China Nuclear Su Energy, while the company's ownership in China Nuclear Su Energy remains unchanged.
Hunan Silver (002716.SZ) director Rongqi resigns
Jiangsu Linyang Energy (601222.SH) holding shareholder Huahong Electronics plans to increase its holdings by 50-100 million yuan.
China National Nuclear Power (601985.SH): Jiangsu Lianyungang Port plans to sell 4% equity stake in China Nuclear Su Energy, while the company's ownership in China Nuclear Su Energy remains unchanged.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
